Incidence of Hypercalcemia and Vertebral Fractures Following Denosumab Withdrawal in Lung Cancer Patients: A Longitudinal Cohort Study
Patients with bony-metastatic lung cancer, especially post-menopausal women, are at risk of fractures and calcium abnormalities after DMAb discontinuation, suggesting that DMAb withdrawal effect may also be present in the oncological setting. A close follow-up and careful monitoring during and after discontinuation of DMAb is necessary.
Authors
- Marta Villanova
- Sharon H. Chou (ORCID: https://orcid.org/0000-0003-2582-050X)
- Le Min (ORCID: https://orcid.org/0000-0003-4363-1139)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- Journal of Bone Metabolism
- Published
- 2025-02-28
- DOI
- https://doi.org/10.11005/jbm.24.803
- Citations
- 4
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.18